Moreover, neutralization of MSTN with and anti-MSTN antibody completely prevented the progression of muscle wasting in a CKD model animal, which implied that MSTN could be a good target for the treatment of PEW in CKD patients [5]. The gene discussed is MSTN; the disease is chronic kidney disease.